These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 549423)

  • 1. Alternative transport pathways of cholephilic 14C-hexobarbital metabolites in rats with experimental hepatitis and cholestasis.
    Richter E; Joeres R; Buschmann J; Zilly W
    Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):429-34. PubMed ID: 549423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hexobarbital-oxidation in vivo and in vitro in rats with bile duct ligation or ANIT-cholestasis (author's transl)].
    Brachtel D; Gallenkamp H; Richter E
    Z Gastroenterol; 1977 Jun; 15(6):378-80. PubMed ID: 888487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary excretion of taurocholate, organic anions and vinblastine in rats with alpha-naphthylisothiocyanate-induced cholestasis.
    Kurihara H; Sano N; Takikawa H
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1069-74. PubMed ID: 15955216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of an experimental hepatitis on the metabolic disposition of 3-o-(+)-[14C]methylcatechin in the rat.
    Hackett AM; Griffiths LA
    Drug Metab Dispos; 1983; 11(6):602-6. PubMed ID: 6140147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Symposion B: Experimental cholestasis--in vitro metabolism and in vivo metabolic clearance of hexobarbital in rats with ANIT-cholestasis].
    Richter E; Brachtel D; Gallenkamp H; Zilly W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():269-71. PubMed ID: 829378
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of metabolism in the biliary excretion of methadone metabolites.
    Roerig DL; Hasegawa AT; Wang RI
    J Pharmacol Exp Ther; 1976 Oct; 199(1):93-102. PubMed ID: 978487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver.
    Baumgartner U; Hardison WG; Miyai K
    Lab Invest; 1987 Jun; 56(6):576-82. PubMed ID: 3599905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary elimination of bendamustin (Cytostasan) in rats.
    Bezek S; Scasnár V; Trnovec T; Grupe R
    Pharmazie; 1991 Nov; 46(11):810-1. PubMed ID: 1811234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of intrahepatic cholestasis by alpha-naphthylisothiocyanate in rats.
    Krell H; Höke H; Pfaff E
    Gastroenterology; 1982 Mar; 82(3):507-14. PubMed ID: 7054045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism and excretion of [14C]imipramine in an experimental hepatitis.
    Hackett AM; Shaw IC; Griffiths LA
    Xenobiotica; 1984 Jun; 14(6):491-9. PubMed ID: 6475108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administration.
    Kossor DC; Meunier PC; Handler JA; Sozio RS; Goldstein RS
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):108-14. PubMed ID: 8470113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactosamine prevents ethinylestradiol-induced cholestasis.
    Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Mottino AD; Pozzi EJ
    Drug Metab Dispos; 2006 Jun; 34(6):993-7. PubMed ID: 16554370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mechanism of action of phenobarbital on the metabolism of 131J-B.S.P. in cholestasis induced by ANIT in isolated and perfused rat liver (author's transl)].
    Tăpălagă D; Suciu A; Schvartz M; Duca S
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(5):233-7. PubMed ID: 548265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid-induced inhibition in the biotransformation of [14C] diphenylhydantoin in rat.
    Buttar HS
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):35-57. PubMed ID: 905633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No increase of biliary permeability in ethinylestradiol-treated rats.
    Jaeschke H; Krell H; Pfaff E
    Gastroenterology; 1983 Oct; 85(4):808-14. PubMed ID: 6884706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier.
    Brouwer KL; Jones JA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolism of hexobarbital in patients with acute hepatitis and cirrhosis (author's transl)].
    Richter E; Gallenkamp H; Keller B; Brachtel D; Zilly W; Breimer DD
    Z Gastroenterol; 1977 Jun; 15(6):381-8. PubMed ID: 888488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats.
    Kostrubsky VE; Vore M; Kindt E; Burliegh J; Rogers K; Peter G; Altrogge D; Sinz MW
    Drug Metab Dispos; 2001 Dec; 29(12):1561-6. PubMed ID: 11717175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.